Adma Biologics (ADMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 48,006 | 73,616 | 16,534 | 22,755 | 42,368 |
| Receivables | 7,316 | 5,087 | 1,310 | 1,392 | 4,127 |
| Inventories | 40,285 | 23,590 | 18,440 | 18,616 | 13,877 |
| TOTAL | $97,323 | $103,889 | $38,334 | $44,530 | $62,503 |
| Non-Current Assets | |||||
| PPE Net | 30,713 | 29,445 | 29,695 | 30,116 | 30,363 |
| Intangibles | 6,900 | 7,111 | 7,323 | 7,534 | 7,745 |
| Other Non-Current Assets | 2,843 | 2,829 | 2,768 | 6,697 | 5,735 |
| TOTAL | $40,457 | $39,385 | $39,786 | $44,347 | $43,842 |
| Total Assets | $137,780 | $143,274 | $78,120 | $88,877 | $106,345 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 29 |
| Accounts payable and accrued liabilities | 8,960 | 6,788 | 5,480 | 5,900 | 5,268 |
| Accrued Expenses | 4,763 | 2,975 | 2,506 | 3,552 | 4,453 |
| TOTAL | $15,150 | $10,129 | $8,338 | $9,625 | $9,893 |
| Non-Current Liabilities | |||||
| Long Term Debt | 82,739 | 82,359 | 55,767 | 41,315 | 41,146 |
| Deferred Revenues | 1,198 | 143 | 143 | 143 | 143 |
| Other Non-Current Liabilities | 120 | 133 | 145 | 15,643 | 15,660 |
| TOTAL | $86,512 | $86,240 | $59,743 | $59,481 | $59,246 |
| Total Liabilities | $101,662 | $96,368 | $68,081 | $69,106 | $69,139 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 59,318 | 59,318 | 46,380 | 46,353 | 46,351 |
| Common Shares | 6 | 6 | 5 | 5 | 5 |
| Retained earnings | -254,156 | -242,717 | -229,505 | -216,437 | -198,399 |
| TOTAL | $36,118 | $46,906 | $10,039 | $19,770 | $37,206 |
| Total Liabilities And Equity | $137,780 | $143,274 | $78,120 | $88,877 | $106,345 |